A Protective Role for Human IL-10–Expressing CD4+ T Cells in Colitis

IL-10 is an immunoregulatory cytokine expressed by numerous cell types. Studies in mice confirm that different IL-10–expressing cell subsets contribute differentially to disease phenotypes. However, little is known about the relationship between cell- or tissue-specific IL-10 expression and disease susceptibility in humans. In this study, we used the previously described human (h)IL10BAC transgenic model to examine the role of hIL-10 in maintaining intestinal homeostasis. Genomically controlled hIL-10 expression rescued Il10−/− mice from Helicobacter-induced colitis and was associated with control of proinflammatory cytokine expression and Th17 cell accumulation in gut tissues. Resistance to colitis was associated with an accumulation of hIL-10–expressing CD4+Foxp3+ regulatory T cells specifically within the lamina propria but not other secondary lymphoid tissues. Cotransfer of CD4+CD45RBlo cells from Il10−/−/hIL10BAC mice rescued Rag1−/− mice from colitis, further suggesting that CD4+ T cells represent a protective source of hIL-10 in the colon. In concordance with an enhanced capacity to express IL-10, CD4+CD44+ T cells isolated from the lamina propria exhibited lower levels of the repressive histone mark H3K27Me3 and higher levels of the permissive histone mark acetylated histone H3 in both the human and mouse IL10 locus compared with the spleen. These results provide experimental evidence verifying the importance of T cell-derived hIL-10 expression in controlling inflammation within the colonic mucosa. We also provide molecular evidence suggesting the tissue microenvironment influences IL-10 expression patterns and chromatin structure in the human (and mouse) IL10 locus.

[1]  R. Sartor,et al.  Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. , 2011, Gastroenterology.

[2]  B. Pulendran,et al.  Functional Specializations of Intestinal Dendritic Cell and Macrophage Subsets That Control Th17 and Regulatory T Cell Responses Are Dependent on the T Cell/APC Ratio, Source of Mouse Strain, and Regional Localization , 2011, The Journal of Immunology.

[3]  T. Tedder,et al.  IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. , 2011, The American journal of pathology.

[4]  E. El-Omar,et al.  Could Helicobacter organisms cause inflammatory bowel disease? , 2011, FEMS immunology and medical microbiology.

[5]  G. Juyal,et al.  An Investigation of Genome-Wide Studies Reported Susceptibility Loci for Ulcerative Colitis Shows Limited Replication in North Indians , 2011, PloS one.

[6]  J. Bream,et al.  Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27. , 2010, Molecular immunology.

[7]  R. D. Hatton,et al.  Regulation of the Ifng locus in the context of T‐lineage specification and plasticity , 2010, Immunological reviews.

[8]  M. Rybicka,et al.  [Helicobacter spp. infections in chronic liver damage]. , 2010, Postępy Higieny i Medycyny Doświadczalnej.

[9]  J. Wu,et al.  Helicobacter pylori Impairs Murine Dendritic Cell Responses to Infection , 2010, PloS one.

[10]  Y. Belkaid,et al.  Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. , 2009, Immunity.

[11]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[12]  L. Feigenbaum,et al.  A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome , 2009, Proceedings of the National Academy of Sciences.

[13]  Christopher B Wilson,et al.  Epigenetic control of T-helper-cell differentiation , 2009, Nature Reviews Immunology.

[14]  L. Hale,et al.  Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. , 2008, Comparative medicine.

[15]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[16]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[17]  M. Denis,et al.  Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. , 2008, The Journal of clinical investigation.

[18]  A. Rudensky,et al.  Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10 , 2007, Nature Immunology.

[19]  F. Sutterwala,et al.  Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. , 2006, Immunity.

[20]  Werner Müller,et al.  Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA , 2006, European journal of immunology.

[21]  F. Powrie,et al.  Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 , 2006, The Journal of Immunology.

[22]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[23]  F. Powrie,et al.  Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.

[24]  B. Stockinger,et al.  CD4+ memory T cells: functional differentiation and homeostasis , 2006, Immunological reviews.

[25]  K. Rajewsky,et al.  T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.

[26]  J. Sundberg,et al.  Refined histopathologic scoring system improves power todetect colitis QTL in mice , 2004, Mammalian Genome.

[27]  F. Powrie,et al.  Colitogenic Th1 Cells Are Present in the Antigen-Experienced T Cell Pool in Normal Mice: Control by CD4+ Regulatory T Cells and IL-101 , 2003, The Journal of Immunology.

[28]  E. Leiter,et al.  Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. , 2002, Inflammatory bowel diseases.

[29]  A. Sher,et al.  Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus–induced Colitis , 2002, The Journal of experimental medicine.

[30]  K. Gaston,et al.  The interleukin-10 - 1082 G/A polymorphism: allele frequency in different populations and functional significance , 2002, Cellular and Molecular Life Sciences CMLS.

[31]  J. Mansfield,et al.  Role of Polymorphisms in the Interleukin-10 Gene in Determining Disease Susceptibility and Phenotype in Inflamatory Bowel Disease , 2001, Digestive Diseases and Sciences.

[32]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[33]  Fiona Powrie,et al.  An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation , 1999, The Journal of experimental medicine.

[34]  P. Woo,et al.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[35]  F. Powrie,et al.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus , 1997, Infection and immunity.

[36]  C. Besch-Williford,et al.  Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents , 1997, Journal of clinical microbiology.

[37]  M. Leach,et al.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.

[38]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[39]  R. Coffman,et al.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell- mediated immunity , 1994, The Journal of experimental medicine.

[40]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[41]  F. Powrie,et al.  Control of immune pathology by IL-10-secreting regulatory T cells , 2004, Springer Seminars in Immunopathology.

[42]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.